VEGFA and macular retinal edema: Large‐scale clinical trials have demonstrated the efficacy of anti‐vascular endothelial growth factor therapy (anti‐VEGF) in treating patients with RVO complicated by macular oedema (ME) (Brown et al. 2011; Campochiaro et al. 2011; Boyer et al. 2012; Heier et al. 2014; Ogura et al. 2014).